Proton Pump Inhibitors (Milestones in Drug Therapy) - Image 1

£147.84

Birkhauser Proton Pump Inhibitors (Milestones in Drug Therapy)

Name: Proton Pump Inhibitors (Milestones in Drug Therapy)
Brand: Birkhauser
Price: 147.84 GBP
Availability: InStock

Gastroenterology

This is the most expensive it has ever been. Walk away.

£148 today · previous high £148 · all-time low £148

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 70 days • 70 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 70 days • 1 price levels

Days at Price

Price Analysis

Most common price: £148 (70 days, 100.0%)

Price range: £148 - £148

Price levels: 1 different prices over 70 days

Description

Inhibition of the proton pump in the parietal cells has been established as the main therapeutic principle in the treatment of acid-related diseases, such as peptic ulcer and gastro-oesophageal reflux. The proton pump inhi bitors are tailored for their purpose. They accumulate in the target cell, are activated by acid and bind strongly to the specific target - the proton pump. The clinical superiority of the proton pump inhibitors is due not only to their high efficacy but also to the long duration of the acid inhibition in comparison with other antisecretory drugs. At present when drug discovery mostly relies on identification and characterization of potential targets by genome research, molecular biology, combinatorial chemistry and automated screening, it seems worthwhile to present the development of the tITst proton pump inhibitor - omeprazol- starting from a chemical structure with an observed antisecretory effect but also severe toxic effects that had to be eliminated. As always, basic and applied research operate luind in hand to optimize the delicate balance be tween efficacy and safety of a new drug. This goal often involves time and many different specialists.

Product Specifications

Brand: Birkhauser
Format: hardcover
ASIN: 3764358971
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Gastroenterology
Domain: Amazon UK
Release Date: 01 April 1999
Listed Since: 18 October 2006

Barcode

No barcode data available

Birkhauser Proton Pump Inhibitors (Milestones in Drug Therapy)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Pharmacology of Peptic Ulcer Disease: 99 (Handbook of Experimental Pharmacology, 99)

Drug Development: Molecular Targets for GI Diseases

Omeprazole: A comparative in vitro dissolution study of different brands of omeprazole magnesium with reference product Losec 20

Mechanisms and Consequences of Proton Transport

Mechanisms and Consequences of Proton Transport

Progress in Drug Research: 50

Pharmacotherapy of Gastrointestinal Inflammation (Progress in Inflammation Research)

COX-2 Inhibitors (Milestones in Drug Therapy)

HMG-CoA Reductase Inhibitors (Milestones in Drug Therapy)

Recombinant Protein Drugs (Milestones in Drug Therapy)

Advances in Esophageal Pain

Calcium Channel Blockers (Milestones in Drug Therapy)

Diagnosis and Treatment of Gastroesophageal Reflux Disease

Calcium Channel Blockers (Milestones in Drug Therapy)

Diseases of the Gastroesophageal Mucosa: The Acid-Related Disorders (Clinical Gastroenterology)

Hepatitis Prevention and Treatment (Milestones in Drug Therapy)

Progress in Drug Research: 60

Metalloproteinases as Targets for Anti-Inflammatory Drugs (Progress in Inflammation Research)

Progress in Drug Research: v. 55

Recent Advances in the Pathophysiology of COPD (Progress in Inflammation Research)

Management of Helicobacter pylori-Related Diseases, An Issue of Gastroenterology Clinics of North America (Volume 44-3) (The Clinics: Internal Medicine, Volume 44-3)

Endoscopic Therapy for Gastroesophageal Reflux Disease

Hepatitis Prevention and Treatment (Milestones in Drug Therapy)

Applications of Pharmacokinetic Principles in Drug Development